nnc0480-0389
Showing 1 - 4 of 4
Healthy Volunteers, Overweight, Obesity Trial in Groningen (NNC0480-0389, Semaglutide, Placebo (NNC0480-0389))
Completed
- Healthy Volunteers
- +3 more
- NNC0480-0389
- +3 more
-
Groningen, NetherlandsNovo Nordisk Investigational Site
Mar 23, 2022
Healthy Volunteers Type 2 Diabetes Trial in Fukuoka (NNC0480-0389, Placebo (NNC0480-0389), Semaglutide)
Completed
- Healthy Volunteers Type 2 Diabetes
- NNC0480-0389
- +3 more
-
Fukuoka, JapanNovo Nordisk Investigational Site
Sep 13, 2021
Diabetes, Type 2 Trial in Berlin (NNC0480-0389)
Recruiting
- Diabetes Mellitus, Type 2
- NNC0480-0389
-
Berlin, GermanyNovo Nordisk Investigational Site
Sep 3, 2021
Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))
Recruiting
- Diabetes Mellitus, Type 2
- NNC0480-0389
- +3 more
-
Buena Park, California
- +95 more
Mar 31, 2022